Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 3129 - 3136 of 12142 results

Murky Rules Complicate ADA Compliance Online

July 2, 2021| News

What’s New in 5G - July 2021

July 1, 2021| Blog| Viewpoint

Patent Owner Tip #11 for Surviving an Instituted IPR: Use It or Lose It (in the POR)

July 1, 2021| Blog| Viewpoint

Plan Distribution Disclosures and Enhanced Communications

July 1, 2021| News

CCPA Reporting Deadline Reminder

June 30, 2021| Blog| Viewpoint

Sports Lawyers Association: The Alston Case Decision, What It Means and Where Might it Lead

June 30, 2021| Podcast| Viewpoint

Mintz Life Sciences Deal Activity (April – June 2021)

June 30, 2021| Article| Viewpoint

Free Laptops? Paid Fellowships? SCOTUS Redefines NCAA Amateurism Status

June 29, 2021| News

News & Press Releases

Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash

September 16, 2025

Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.

Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber

September 15, 2025

Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering

September 12, 2025

Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”

View all News and Press Releases